Hematology RSS : Gourt http://www.gourt.com/Health/Medicine/Medical-Specialties/Hematology.html en-us Copyright 2007, Gourt.com 2009-07-04T22:09+35:00 rtruog@gourt.com rtruog@gourt.com Hematology RSS : Gourt hourly 1 1901-01-01T00:00+00:00 Permanent Hematology-Oncology Job in Amarillo, TX Seeks 2 Hem/Onc providers Texas with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_texas/page_7.html Permanent Hematology-Oncology Job in Upstate New York New York with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_new_york/page_4.html Permanent Hematology-Oncology Job in Southern Illinois Illinois with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_illinois/page_9.html Permanent Hematology-Oncology Job in Corpus Christi, TX Area Texas with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_texas/page_6.html Permanent Hematology-Oncology Job in St. Cloud, MN Minnesota with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_minnesota/page_2.html Permanent Hematology-Oncology Job in Abilene, TX opportunity Texas with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_texas/page_4.html Permanent Hematology-Oncology Job in Panhandle of Florida Florida with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_florida/page_12.html Permanent Hematology-Oncology Job in Closed proximity to Philly & Baltimore Pennsylvania with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_pennsylvania/page_13.html Permanent Hematology-Oncology Job in Kansas City, KS Academic opportunity Kansas with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_kansas/page_3.html Permanent Hematology-Oncology Job in Academic Opportunity in Arizona Arizona with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_arizona/page_8.html Permanent Hematology-Oncology Job in Southwest Arizona Arizona with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_arizona/page_7.html Permanent Hematology-Oncology Job in EXCELLENT OPPORTUNITY in a prestigious college tow Pennsylvania with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_pennsylvania/page_9.html Permanent Hematology-Oncology Job in Practice is less than 2 hours from Raleigh, NC North Carolina with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_north_carolina/page_15.html Permanent Hematology-Oncology Job in Great Location 1 hours from Portland Oregon with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_oregon/page_8.html Permanent Hematology-Oncology Job in Northwest North Carolina North Carolina with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_north_carolina/page_13.html Permanent Hematology-Oncology Job in East Central Georgia Georgia with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_georgia/page_11.html Permanent Hematology-Oncology Job in Northwestern Wyoming Position Wyoming with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_wyoming/page_2.html Permanent Hematology-Oncology Job in Opportunity in Central Washington Washington with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_washington/page_12.html Permanent Hematology-Oncology Job in Beautiful, Sunny, Fort Lauderdale Florida with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_florida/page_11.html Permanent Hematology-Oncology Job in Southwest Oregon Oregon with Enterprise Medical Service http://www.physemp.com/physician_jobs/all_hematology_oncology_jobs_in_oregon/page_7.html New antimicrobial agents for the treatment of bacterial infections in cancer patients http://dx.doi.org/10.1002%2Fhon.898 How would I manage a sample submitted for flow cytometry analysis for suspicious chronic lymphocytic leukaemia http://dx.doi.org/10.1002%2Fhon.900 Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy http://dx.doi.org/10.1002%2Fhon.901 Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity http://dx.doi.org/10.1002%2Fhon.904 Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy http://dx.doi.org/10.1002%2Fhon.902 20 RBCU was 7.6 (95% Confidence Intervals [CI] 1.2-49.3) and for ICT was 0.15 (0.03-0.77). In conclusion, 61% of PMF patients developed RBC-TD which portended inferior OS; however patients receiving ICT had comparatively improved OS, suggesting a clinical benefit. Prospective studies of IOL and the impact of ICT in PMF are warranted. Copyright © 2009 John Wiley & Sons, Ltd.]]> Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia http://dx.doi.org/10.1002%2Fhon.903 500/cmm and platelets >20000/cmm was 10 and 13, respectively. In order to perform a comparison in terms of haematological and non haematological toxicity, a group of 30 patients, who were previously autografted after conditioning with IDA and oral Bu was considered. Selection of factors for a matched pair analysis included median age, percentage of subjects aged over 60 years, median CD34+ cell received, cytogenetic and molecular findings and per cent of secondary AML. As compared to previous series, the occurrence of severe mucositis was dramatically reduced (80% vs. 12%, p < 0.0001). In addition, need and duration of total parenteral nutrition (TPN), iv antibiotic therapy and hospitalization were also significantly reduced. We conclude that replacement of oral with intravenous BU results in a more favourable toxicity profile. A longer follow-up is required to assess a potential advantage in terms of disease free survival (DFS). Copyright © 2009 John Wiley & Sons, Ltd.]]> The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma http://dx.doi.org/10.1002%2Fhon.896 Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma? http://dx.doi.org/10.1002%2Fhon.897 KHSV- EBV- post-transplant effusion lymphoma with plasmablastic features: variant of primary effusion lymphoma? http://dx.doi.org/10.1002%2Fhon.892 Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial http://dx.doi.org/10.1002%2Fhon.886 Comorbidities and FLT3-ITD abnormalities as independent prognostic indicators of survival in Elderly acute myeloid leukaemia patients http://dx.doi.org/10.1002%2Fhon.889 65 years diagnosed as having AML between January 2001 and December 2005. Comorbidities were evaluated by using Charlson comorbidity index (CCI), Hematopoietic cell transplantation comorbidity index (HCTCI) and a score proposed by Dombret et al. in 2007. Median patient age was 67 years. Forty-six patients were treated with intensive chemotherapy and 23 reached a complete remission. Seventy-four patients received only supportive therapies or low-dose chemotherapy. Multivariate analysis showed the effects of leukocytosis (p = 0.0013), antecedent Myelodysplastic syndrome (MDS) (p = 0.011), FLT3 abnormalities (p = 0.032), CCI (p = 0.0037) and Dombret et al. score (p = 0.045) as independent prognostic parameters for survival. Based on these variables we were able to stratify patients in low and high risk, with different median overall survival: patients were considered as low risk if they had none or only one of the above mentioned adverse factors for survival, with a median overall survival of 447 days. Patients with two or more adverse factors were categorized as high risk: this subgroup had a median overall survival of 227 days (p = 0.001). Comorbidities are independent factors that influence survival. Application of CCI and Dombret score may help to better identify patients at diagnosis who can benefit from intensive chemotherapy. Copyright © 2009 John Wiley & Sons, Ltd.]]> Involved field radiotherapy for limited stage Hodgkin lymphoma: balancing treatment efficacy against long-term toxicities http://dx.doi.org/10.1002%2Fhon.890 A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03 http://dx.doi.org/10.1002%2Fhon.891 Analysis of Bcr-Abl kinase domain mutations in Korean chronic myeloid leukaemia patients: poor clinical outcome of P-loop and T315I mutation is disease phase dependent http://dx.doi.org/10.1002%2Fhon.894 MPL W515L/K mutations in 343 Chinese adults with JAK2V617F mutation-negative chronic myeloproliferative disorders detected by a newly developed RQ-PCR based on TaqMan MGB probes http://dx.doi.org/10.1002%2Fhon.899 CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL http://dx.doi.org/10.1002%2Fhon.888 Thrombocytopenia as first manifestation of splenic angiosarcoma http://www.springerlink.de/content/r3q00x268gn26412/ Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin http://www.springerlink.de/content/y727411813210568/ Lenalidomide in 5q minus myelodysplastic syndrome: how long is enough? http://www.springerlink.de/content/t7700283t0w040g7/ Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine http://www.springerlink.de/content/w20pt451t5836172/ Clostridium difficile-associated diarrhoea, a frequent complication in patients with acute myeloid leukaemia http://www.springerlink.de/content/y76k77m735826284/ Improvement of the thermal amplitude after rituximab treatment for cold agglutinin disease with Waldenström’s macroglobulinemia http://www.springerlink.de/content/067257417555w82q/ Thrombocytopenia with rituximab treatment—splenomegaly as the risk factor http://www.springerlink.de/content/b824247102681818/ Post-rituximab Burkitt transformation of PTLD: loss of CD20 expression accompanied by a switch in light-chain expression http://www.springerlink.de/content/t0w663172728h7u6/ Total therapy-based treatment for multiple myeloma—a single center experience http://www.springerlink.de/content/80134k89k48h2546/ Peri-operative thrombosis prophylaxis in the Chinese versus Caucasian population http://www.springerlink.de/content/m488168421528352/ A prognostic score for AIDS-related diffuse large B-cell lymphoma in Brazil http://www.springerlink.de/content/231788t374452x26/ Non-Hodgkin lymphoma involving stomach and ovary: extending the Krukenberg tumor concept http://www.springerlink.de/content/935320832q847917/ Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection http://www.springerlink.de/content/p3156p6044m37487/ Echocardiographic findings in patients with sickle cell disease http://www.springerlink.de/content/fpm3413p67692rp5/ Prevalence and analysis of t(14;18) and t(11;14) chromosomal translocations in healthy Indian population http://www.springerlink.de/content/77520193tp620619/ A novel beta-globin mutation (HBB:c.107A>G; or codon 35 β (A→G)) at alpha–beta chain interfaces http://www.springerlink.de/content/n7114k47g2315036/ G; or codon 35 β (A→G)) at alpha–beta chain interfaces Content Type Journal ArticleCategory Letter to the EditorDOI 10.1007/s00277-009-0760-4Authors Ravindra Kumar, Sanjay Gandhi Postgraduate Institute of Medical Sciences Department of Genetics Lucknow UP India 226014Parag M. Tamhankar, Sanjay Gandhi Postgraduate Institute of Medical Sciences Department of Genetics Lucknow UP India 226014Inusha Panigrahi, Postgraduate Institute of Medical Education and Research Department of Pediatrics Chandigarh IndiaAshwin Dalal, Center for DNA Fingerprinting and Diagnostics Diagnostic Division Hyderabad IndiaSarita Agarwal, Sanjay Gandhi Postgraduate Institute of Medical Sciences Department of Genetics Lucknow UP India 226014 Journal Annals of HematologyOnline ISSN 1432-0584Print ISSN 0939-5555 ]]> Screening of platelet concentrates for bacterial contamination: spectrum of bacteria detected, proportionof transfused units, and clinical follow-up http://www.springerlink.de/content/325m474740226u02/ The same genetic defect in three Tunisian families with Bernard Soulier syndrome: a probable founder Stop mutation in GPIbbeta http://www.springerlink.de/content/tv8514v621080wm2/ Treatment of K562 cells with 1,25-dihydroxyvitamin D3 induces distinct alterations in the expression of apoptosis-related genes BCL2, BAX, BCLXL, and p21 http://www.springerlink.de/content/r7806148m515778g/ Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin’s lymphoma http://www.springerlink.de/content/0217n3262l080865/ Iron overload and chronically transfused patients: Numbers, scales, and clinical research http://dx.doi.org/10.1002%2Fajh.21467 Synergistic antitumor effects of lenalidomide and rituximab on mantle cell lymphoma in vitro and in vivo http://dx.doi.org/10.1002%2Fajh.21468 The role of antiphospholipid antibodies toward the protein C/protein S system in venous thromboembolic disease http://dx.doi.org/10.1002%2Fajh.21466 Acute weight gain and diastolic dysfunction as a potent risk complex for post stem cell transplant atrial fibrillation http://dx.doi.org/10.1002%2Fajh.21459 FLT3 mutations have no prognostic impact in elderly patients with acute myeloid leukemia and normal karyotype http://dx.doi.org/10.1002%2Fajh.21458 Quantifying the reduction in immunoglobulin use over time in patients with chronic immune thrombocytopenic purpura receiving romiplostim (AMG 531) http://dx.doi.org/10.1002%2Fajh.21463 Overexpression of nucleolin in engrafted acute myelogenous leukemia cells http://dx.doi.org/10.1002%2Fajh.21461 An age-adapted approach for the use of D-dimers in the exclusion of deep venous thrombosis http://dx.doi.org/10.1002%2Fajh.21455 Paraneoplastic pemphigus associated with systemic mastocytosis http://dx.doi.org/10.1002%2Fajh.21462 Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia http://dx.doi.org/10.1002%2Fajh.21457 85% of patients. Nevertheless, between 15 and 20% of patients may evolve to blastic phase. Measurement of low level or "minimal" residual disease using molecular tests is becoming the gold-standard approach to measure response to therapy due to its higher sensitivity compared to other routine techniques. The technical aspects and clinical applications of molecular monitoring will be the main focus of this article. Am. J. Hematol., 2009. © 2009 Wiley-Liss, Inc.]]> Changes in red cell ion transport, reduced intratumoral neovascularization, and some mild motor function abnormalities accompany targeted disruption of the Mouse Kell gene (Kel) http://dx.doi.org/10.1002%2Fajh.21453 Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease http://dx.doi.org/10.1002%2Fajh.21456 Hemoglobin lansing: A novel hemoglobin variant causing falsely decreased oxygen saturation by pulse oximetry http://dx.doi.org/10.1002%2Fajh.21452 DHFR 19-bp insertion/deletion polymorphism and MTHFR C677T in adult acute lymphoblastic leukaemia: Is the risk reduction due to intracellular folate unbalancing? http://dx.doi.org/10.1002%2Fajh.21451 Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant http://dx.doi.org/10.1002%2Fajh.21449 Sequential evaluation of serum hepcidin in anemic myeloma patients: Study of correlations with myeloma treatment, disease variables, and anemia response http://dx.doi.org/10.1002%2Fajh.21448 Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea http://dx.doi.org/10.1002%2Fajh.21446 3rd Annual Sickle Disease Research and Educational Symposium and Annual National Sickle Cell Disease Scientific Meeting http://dx.doi.org/10.1002%2Fajh.21445 Osteopetrosis - More than only a disease of the bone http://dx.doi.org/10.1002%2Fajh.21454 2009 BioIron Program Book http://dx.doi.org/10.1002%2Fajh.21464 A single-center experience in 20 patients with infantile malignant osteopetrosis http://dx.doi.org/10.1002%2Fajh.21447 Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia http://dx.doi.org/10.1002%2Fajh.21438 Genome-wide association studies and the genetic dissection of complex traits http://dx.doi.org/10.1002%2Fajh.21440 Hydroxycarbamide-induced dermopathy http://dx.doi.org/10.1002%2Fajh.21421 Near total effacement of bone marrow by medulloblastoma http://dx.doi.org/10.1002%2Fajh.21410 Dutcher bodies http://dx.doi.org/10.1002%2Fajh.21399 Russell bodies and Mott cells http://dx.doi.org/10.1002%2Fajh.21397 MRI findings in aplastic anemia http://dx.doi.org/10.1002%2Fajh.21394 A T-lineage neoplasm - Which one? http://dx.doi.org/10.1002%2Fajh.21403 Symptomatic intracardiac diffuse large B-cell lymphoma http://dx.doi.org/10.1002%2Fajh.21329 Monoblastic sarcoma cutis preceding acute monoblastic leukemia http://dx.doi.org/10.1002%2Fajh.21326 Petechial bleeding after sunburn in a patient with mild thrombocytopenia http://dx.doi.org/10.1002%2Fajh.21321 CLINICAL PROFILE AND HOME MANAGEMENT OF SICKLE CELL-RELATED PAIN: The Enugu (Nigeria) Experience http://www.informaworld.com/smpp/content~content=a912889221~db=all~jumptype=rss THE BENEFIT OF ATG IN IMMUNOSUPPRESSIVE THERAPY OF CHILDREN WITH MODERATE APLASTIC ANEMIA http://www.informaworld.com/smpp/content~content=a912890325~db=all~jumptype=rss RHABDOMYOSARCOMA OF THE EXTREMITIES: A Focus on Tumors Arising in the Hand and Foot http://www.informaworld.com/smpp/content~content=a912887479~db=all~jumptype=rss INCIDENCE OF PRIMARY CENTRAL NERVOUS SYSTEM TUMORS AMONG CHILDREN IN BELGRADE (SERBIA), 1991-2004 http://www.informaworld.com/smpp/content~content=a912887591~db=all~jumptype=rss PANEL REACTIVE ANTIBODY IN THALASSEMIC SERUM INHIBITS PROLIFERATION AND DIFFERENTIATION OF CORD BLOOD CD34 + CELLS IN VITRO http://www.informaworld.com/smpp/content~content=a912889983~db=all~jumptype=rss ALLOGENEIC STEM CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROMES IN CHILDREN: A Report from the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON) http://www.informaworld.com/smpp/content~content=a912888004~db=all~jumptype=rss SEVERE HYPOCHROMIC MICROCYTIC ANEMIA IN A PATIENT WITH CONGENITAL ATRANSFERRINEMIA http://www.informaworld.com/smpp/content~content=a912888061~db=all~jumptype=rss EFFECT OF SOMATOSTATIN ANALOGUE OCTREOTIDE IN MEDULLOBLASTOMA IN XENOGRAFT AND CELL CULTURE STUDY http://www.informaworld.com/smpp/content~content=a912889236~db=all~jumptype=rss SUCCESSFUL TREATMENT OF KASABACH-MERRITT SYNDROME WITH VINCRISTINE AND DIAGNOSIS OF THE HEMANGIOMA USING THREE-DIMENSIONAL IMAGING http://www.informaworld.com/smpp/content~content=a912889492~db=all~jumptype=rss A NOVEL L218P MUTATION IN NADH-CYTOCHROME B5 REDUCTASE ASSOCIATED WITH TYPE I RECESSIVE CONGENITAL METHEMOGLOBINEMIA http://www.informaworld.com/smpp/content~content=a912887513~db=all~jumptype=rss PLASMA HEPARANASE AS A SIGNIFICANT MARKER OF TREATMENT RESPONSE IN CHILDREN WITH HODGKIN LYMPHOMA: Pilot Study http://www.informaworld.com/smpp/content~content=a911106651~db=all~jumptype=rss ALLOGENEIC CORD BLOOD TRANSPLANTATION IN CHILDREN WITH HEMATOLOGICAL MALIGNANCIES: A Long-Term Follow-Up Single-Center Study http://www.informaworld.com/smpp/content~content=a911109013~db=all~jumptype=rss EXTRA-OSSEOUS EWING SARCOMA http://www.informaworld.com/smpp/content~content=a911096517~db=all~jumptype=rss BONE MARROW TRANSPLANTATION OR HYDROXYUREA FOR SICKLE CELL ANEMIA: Long-Term Effects on Semen Variables and Hormone Profiles http://www.informaworld.com/smpp/content~content=a911100515~db=all~jumptype=rss ANTIBODY TITRATION AND IMMUNE RESPONSE OF IRANIAN β-THALASSEMIC PATIENTS TO HEPATITIS B VIRUSE VACCINE (BOOSTER EFFECT) http://www.informaworld.com/smpp/content~content=a911115025~db=all~jumptype=rss GROWTH STATUS IN CHILDREN AND ADOLESCENTS WITH SICKLE CELL DISEASE http://www.informaworld.com/smpp/content~content=a911099888~db=all~jumptype=rss CD10 AND CD34 EXPRESSION IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN MOROCCO: Clinical Relevance and Outcome http://www.informaworld.com/smpp/content~content=a911108151~db=all~jumptype=rss HEPATITIS G VIRUS INFECTION IN MULTITRANSFUSED EGYPTIAN CHILDREN http://www.informaworld.com/smpp/content~content=a911124244~db=all~jumptype=rss TRENDS IN SURVIVAL AFTER CHILDHOOD CANCER IN SLOVENIA BETWEEN 1957 AND 2007 http://www.informaworld.com/smpp/content~content=a911129516~db=all~jumptype=rss SPERM CRYOPRESERVATION PRACTICES AMONG ADOLESCENT CANCER PATIENTS AT RISK FOR INFERTILITY http://www.informaworld.com/smpp/content~content=a911114143~db=all~jumptype=rss SPONTANEOUS THROMBOSIS OF HEPATIC ANEURYSMS IN AN INFANT WITH WISKOTT-ALDRICH SYNDROME http://www.informaworld.com/smpp/content~content=a911121214~db=all~jumptype=rss MULTIPLE CHROMOSOME ABNORMALITIES IN THE PLEURAL FLUID OF A PATIENT WITH RECURRENT EWING SARCOMA http://www.informaworld.com/smpp/content~content=a911102319~db=all~jumptype=rss THROMBOLYTICS FOR HYPERACUTE STROKE IN CHILDREN http://www.informaworld.com/smpp/content~content=a910575591~db=all~jumptype=rss HEMORHEOLOGICAL PARAMETERS IN CHILDREN WITH IRON-DEFICIENCY ANEMIA AND THE ALTERATIONS IN THESE PARAMETERS IN RESPONSE TO IRON REPLACEMENT http://www.informaworld.com/smpp/content~content=a910575883~db=all~jumptype=rss HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILD HEMATOLOGIC MALIGNANCIES WITH G-CSF-MOBILIZED MARROW GRAFTS WITHOUT T-CELL DEPLETION: A Single-Center Report of 45 Cases http://www.informaworld.com/smpp/content~content=a910575627~db=all~jumptype=rss HYPEREOSINOPHILIC SYNDROME IN CHILDHOOD: Clinical and Molecular Features of Two Cases http://www.informaworld.com/smpp/content~content=a910577213~db=all~jumptype=rss THE CASE OF A 1-YEAR-OLD GIRL WITH HEREDITARY HYPERFERRITINEMIA CATARACT SYNDROME http://www.informaworld.com/smpp/content~content=a910576427~db=all~jumptype=rss ANAPLASTIC LARGE CELL LYMPHOMA WITH PRIMARY INVOLVEMENT OF SKELETAL MUSCLE: A Rare Case Report and Review of the Literature http://www.informaworld.com/smpp/content~content=a910575547~db=all~jumptype=rss POLAND SYNDROME WITH INTRACRANIAL GERM CELL TUMOR IN A CHILD http://www.informaworld.com/smpp/content~content=a910575680~db=all~jumptype=rss RHABDOMYOLYSIS DUE TO Escherichia coli SEPSIS IN THREE PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA http://www.informaworld.com/smpp/content~content=a909912007~db=all~jumptype=rss PARVOVIRUS B19-INDUCED PERSISTENT PURE RED CELL APLASIA IN A CHILD WITH T-CELL IMMUNODEFICIENCY http://www.informaworld.com/smpp/content~content=a909912913~db=all~jumptype=rss ALTERED IRON METABOLISM IN CHILDREN WITH HUMAN IMMUNODEFICIENCY VIRUS DISEASE http://www.informaworld.com/smpp/content~content=a909912723~db=all~jumptype=rss ACUTE LYMPHOBLASTIC LEUKEMIA SECONDARY TO CHEMORADIOTHERAPY FOR PERIVASCULAR EPITHELIOID CELL TUMOR OF UTERUS http://www.informaworld.com/smpp/content~content=a909911835~db=all~jumptype=rss CHOOSING THERAPY FOR ADOLESCENT FEMALES WITH CANCER: Fertility Should Matter http://www.informaworld.com/smpp/content~content=a909911945~db=all~jumptype=rss RELAPSE OF PRIMITIVE MEDIASTINAL LYMPHOMA AS A MYELOID MASS FOLLOWING BEAM AUTOLOGOUS TRANSPLANT AND SUBSEQUENT REFRACTORINESS TO MATCHED UNRELATED UMBILICAL CORD BLOOD ALLOGRAFT http://www.informaworld.com/smpp/content~content=a909911931~db=all~jumptype=rss TRANSFORMATION OF MYELODYSPLASTIC SYNDROME TO T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN A YOUNG ADULT http://www.informaworld.com/smpp/content~content=a909911891~db=all~jumptype=rss DIFFERENTIAL microRNA EXPRESSION IN CHILDHOOD B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA http://www.informaworld.com/smpp/content~content=a908622265~db=all~jumptype=rss INCIDENCE OF AND RISK FACTORS FOR CHILDHOOD THROMBOSIS: A Single-Center Experience in Ankara, Turkey http://www.informaworld.com/smpp/content~content=a908623719~db=all~jumptype=rss UNDULANT COURSE OF AFP: A Sign of Tumor Activation or Not? http://www.informaworld.com/smpp/content~content=a908622395~db=all~jumptype=rss IS THE TREATMENT FOR CHILDHOOD SOLID TUMORS ASSOCIATED WITH LOWER BONE MASS THAN THAT FOR LEUKEMIA AND HODGKIN DISEASE? http://www.informaworld.com/smpp/content~content=a908622480~db=all~jumptype=rss EXPRESSION OF PTEN AND SHP1, INVESTIGATED FROM TISSUE MICROARRAYS IN PEDIATRIC ACUTE LYMPHOBLASTIC, LEUKEMIA http://www.informaworld.com/smpp/content~content=a908622353~db=all~jumptype=rss COEXISTENCE OF SYMPTOMATIC IRON-DEFICIENCY ANEMIA AND DUODENAL NODULAR LYMPHOID HYPERPLASIA DUE TO GIARDIASIS: Case Report http://www.informaworld.com/smpp/content~content=a908622329~db=all~jumptype=rss BONE FRACTURE: An Unusual Presentation of Acute Megakaryoblastic Leukemia http://www.informaworld.com/smpp/content~content=a908622409~db=all~jumptype=rss SUCCESSFUL USE OF TERBUTALINE IN PERSISTENT PRIAPISM IN A 12-YEAR-OLD BOY WITH CHRONIC MYELOID LEUKEMIA http://www.informaworld.com/smpp/content~content=a908623975~db=all~jumptype=rss WT1 (WILMS TUMOR 1) PEPTIDE IMMUNOTHERAPY FOR CHILDHOOD RHABDOMYOSARCOMA: A Case Report http://www.informaworld.com/smpp/content~content=a908622520~db=all~jumptype=rss INVASIVE ASPERGILLOSIS OF THE SMALL BOWEL IN AN INFANT WITH ACUTE MYELOID LEUKEMIA AND INTESTINAL OBSTRUCTION http://www.informaworld.com/smpp/content~content=a908622434~db=all~jumptype=rss PLASMA NATRIURETIC PEPTIDES LEVELS AND ECHOCARDIOGRAPHIC FINDINGS IN LATE SUBCLINICAL ANTHRACYCLINE TOXICITY http://www.informaworld.com/smpp/content~content=a906489026~db=all~jumptype=rss PULMONARY HYPERTENSION IN β-THALASSEMIA MAJOR AND THE ROLE OF L-CARNITINE THERAPY http://www.informaworld.com/smpp/content~content=a906492511~db=all~jumptype=rss RESPONSE TO RITUXIMAB AND PREDNISOLONE FOR OPSOCLONUS-MYOCLONUS-ATAXIA SYNDROME IN A CHILD WITH GANGLIONEUROBLASTOMA http://www.informaworld.com/smpp/content~content=a906489008~db=all~jumptype=rss REVIEWER ACKNOWLEDGMENT http://www.informaworld.com/smpp/content~content=a906492123~db=all~jumptype=rss